| 1 |
27095937 | Synergistic effects of sorafenib in combination with gemcitabine or pemetrexed in lung cancer cell lines with K-ras mutations. | 2016 |
1 |
| 2 |
25446102 | Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells. | 2015 Jan 2 |
4 |
| 3 |
23959460 | Effects of pemetrexed, gefitinib, and their combination on human colorectal cancer cells. | 2013 Oct |
1 |
| 4 |
21575631 | Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells. | 2011 Aug 1 |
4 |